With
increased R&D spending on therapeutic drug research, molecular biology has
gained substantial traction during the last decade. It has a wide range of
applications in the healthcare industry, with clinical trials and diagnostic
purposes being the most prevalent. Southern blotting is one such technology
that has acquired great acceptance, providing huge market prospects for firms
across the value chain. The technique was first used to detect the presence of
DNA fragments in materials in the 1970s. The technique is useful not only for
molecular research and development, but also for detecting some of the world's
most common chronic diseases, such as malignancies and hereditary diseases.
In the
fields of genetics and forensic research, the use of Southern blotting is
becoming more common, which is projected to increase demand for better drug
discovery and development. This, in turn, is expected to propel the Southern
blotting market further in the next years. Furthermore, rising need for
speedier detection of chronic diseases such as cancer, congenital adrenal
hyperplasia, and HIV-1, as well as rising prevalence of chronic diseases such
as cancer, congenital adrenal hyperplasia, and HIV-1, are factors driving
market growth. In addition, the application of Southern blot in medical
diagnostics and forensic science is on the rise. However, important barriers to
the growth of the Southern blotting market are the lack of essential
instruments for Southern blotting, high product costs, and limited funding in
developing nations.
The market
for Southern blotting can be divided into four categories: application,
product, end-user, and geography. Medical diagnosis, genetic fingerprinting,
scientific research, agricultural, and sex determination are the applications
that the market is divided into. The market is divided into consumables and
instruments based on the type of product. The market is divided into
biotechnology and pharmaceutical enterprises, research institutes, contract
research organisations, and forensic labs based on end-user.
Southern
blotting is sold in four regions throughout the world: North America, Asia
Pacific, Europe, and the rest of the world. Because of the discovery of
advanced drugs and increased research development, North America is expected to
lead the worldwide market, with the United States as a major contributor. Due
to increased investment in innovative drug research techniques and a large
patient base suffering from chronic diseases, Asia Pacific is expected to rise
at a significant rate. Because of the high prevalence of sickness and the
ageing population in Europe, the market is rapidly expanding.
Comments
Post a Comment